Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment

被引：114
|
作者：
Roden, Dan M. [1 ]
Harrington, Robert A. [2 ]
Poppas, Athena [3 ]
Russo, Andrea M. [4 ,5 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Cardiovasc Med & Clin Pharmacol, Nashville, TN 37232 USA
[2] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[3] Brown Univ, Sch Med, Cardiol Div, Providence, RI 02912 USA
[4] Cooper Univ Hosp, Electrophysiol & Arrhythmia Serv, Camden, NJ USA
[5] Rowan Univ, Cooper Med Sch, Clin Cardiac Electrophysiol Fellowship Program, Camden, NJ USA
来源：
CIRCULATION | 2020年 / 141卷 / 24期
关键词：
arrhythmias; cardiac; COVID-19; drug effects; drug-related side effects and adverse reactions; severe acute respiratory syndrome coronavirus 2; INTERVAL PROLONGATION; AZITHROMYCIN; RISKS;
D O I：
10.1161/CIRCULATIONAHA.120.047521
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E906 / E907
页数：2
相关论文
共 50 条
  • [1] Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment
    Roden, Dan M.
    Harrington, Robert A.
    Poppas, Athena
    Russo, Andrea M.
    HEART RHYTHM, 2020, 17 (07) : E231 - E232
  • [2] Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment
    Roden, Dan M.
    Harrington, Robert A.
    Poppas, Athena
    Russo, Andrea M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (20) : 2623 - 2624
  • [3] COVID-19 Drug Interactions
    Surmelioglu, Nursel
    Demirkan, Kutay
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 : 43 - 45
  • [4] Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice
    Di Lenarda, Andrea
    Ferri, Nicola
    Lanzafame, Massimiliano
    Montuori, Eva Agostina
    Pacelli, Luciano
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [5] Drug-drug Interactions of Antithrombotic Medications During Treatment of COVID-19
    Firat, Oguzhan
    Kelleci Cakir, Burcu
    Demirkan, Kutay
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 18 (01) : 1 - 2
  • [6] Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview
    Rezaee, Haleh
    Pourkarim, Fariba
    Pourtaghi-Anvarian, Samira
    Entezari-Maleki, Taher
    Asvadi-Kermani, Touraj
    Nouri-Vaskeh, Masoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (01):
  • [7] QTc Prolongation in COVID-19 Patients Using Chloroquine
    Matthijs L. Becker
    Dominic Snijders
    Claudia W. van Gemeren
    Hylke Jan Kingma
    Steven F. L. van Lelyveld
    Thijs J. Giezen
    Cardiovascular Toxicology, 2021, 21 : 314 - 321
  • [8] Drug Interactions of Psychiatric and COVID-19 Medications
    Mohebbi, Niayesh
    Talebi, Ali
    Moghadamnia, Marjan
    Taloki, Zahra Nazari
    Shakiba, Alia
    BASIC AND CLINICAL NEUROSCIENCE, 2020, 11 (02) : 185 - 200
  • [9] QTc Prolongation in COVID-19 Patients Using Chloroquine
    Becker, Matthijs L.
    Snijders, Dominic
    van Gemeren, Claudia W.
    Kingma, Hylke Jan
    van Lelyveld, Steven F. L.
    Giezen, Thijs J.
    CARDIOVASCULAR TOXICOLOGY, 2021, 21 (04) : 314 - 321
  • [10] Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps
    Ino, Hiroyasu
    Nakazawa, Eisuke
    Akabayashi, Akira
    CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2021, 30 (01) : 51 - 58
12345